EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nucleic Acid Nanotechnology‐Empowered CRISPR‐Cas12a Systems for Biosensing and Bioimaging Applications

Qian Hou, Jinghan Ren, Yuzhen Wu, Peiran Zhao iD, Shuzhen Yue, Sai Bi

Small Methods · 2026-06 · 10 (12)

DOI: 10.1002/smtd.70666 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 24.04.2026. Verfasst von Qian Hou und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Qingdao Key Laboratory of Molecular Intelligent Engineering and Precision Health, Qingdao University, …. Hauptthemen laut MEDLINE: Biosensing Techniques, CRISPR-Cas Systems, Nanotechnology, Nucleic Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 177 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China, Taishan Scholar Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of highly sensitive and simple bioanalytical platforms is crucial for advancing disease diagnostics and biomedical research. In recent years, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR‐associated (Cas) protein systems have emerged as the “next‐generation molecular technology” that profoundly impacts the field of genome editing and molecular diagnosis. In particular, CRISPR‐Cas12a, an important CRISPR‐Cas family member, has gained prominence as a robust tool in biosensing and bioimaging due to its easy design and high target specificity. Notably, the integration of nucleic acid nanotechnology, including nucleic acid amplification strategies and engineered functional nucleic acids, with CRISPR‐Cas12a systems significantly improves detection sensitivity and specificity, enabling the analysis of low‐abundance analytes. This review introduces the fundamentals of CRISPR‐Cas12a and key nucleic acid‐based toolboxes. Next, we systematically summarize the advantages of nucleic acid nanotechnology‐empowered CRISPR‐Cas12a platforms in detail and highlight recent advances in their applications in biosensing and bioimaging. Finally, current challenges and future perspectives of such nucleic acids‐assisted CRISPR‐Cas12a systems for disease diagnostics are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesCRISPR-Cas SystemsNanotechnologyNucleic AcidsMolecular ImagingHumans

Stichwörter der Autor:innen

CRISPR‐Cas12abioimagingbiosensingmolecular diagnosticsnucleic acid nanotechnology

Substanzen

Nucleic Acids

Autor:innen und Institutionen

  • College of Chemistry and Chemical Engineering, Qingdao Key Laboratory of Molecular Intelligent Engineering and Precision Health, Qingdao University, Qingdao, P. R. China.
  • Shandong Provincial Key Laboratory of Detection Technology For Tumor Markers, College of Medicine, Linyi University, Linyi, P. R. China.
  • Zhong Yuan Academy of Biological Medicine, Liaocheng People's Hospital, Liaocheng, P. R. China.

ORCID-Profile: Peiran Zhao

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China
  • Taishan Scholar Foundation of Shandong Province
  • Open Project of Shandong Provincial Key Laboratory for Tumor Imaging Equipment Development and Tumor Diagnosis & Treatment Integration Technology
  • Innovation and Entrepreneurship Training Program for College Students

Zitieren

APA

Hou, Q., Ren, J., Wu, Y., Zhao, P., Yue, S., & Bi, S. (2026). Nucleic Acid Nanotechnology‐Empowered CRISPR‐Cas12a Systems for Biosensing and Bioimaging Applications. Small Methods, 10(12). https://doi.org/10.1002/smtd.70666

Vancouver

Hou Q, Ren J, Wu Y, Zhao P, Yue S, Bi S. Nucleic Acid Nanotechnology‐Empowered CRISPR‐Cas12a Systems for Biosensing and Bioimaging Applications. Small Methods. 2026;10(12). doi:10.1002/smtd.70666

BibTeX
@article{Hou2026,
  author = {Hou, Qian and Ren, Jinghan and Wu, Yuzhen and Zhao, Peiran and Yue, Shuzhen and Bi, Sai},
  title = {Nucleic Acid Nanotechnology‐Empowered CRISPR‐Cas12a Systems for Biosensing and Bioimaging Applications},
  journal = {Small Methods},
  year = {2026},
  volume = {10},
  number = {12},
  doi = {10.1002/smtd.70666}
}
Kostenlos starten →